Besties Regeneron and Sanofi Add Another $1B to PD-1 I/O Deal Post author:Sam Post published:January 7, 2018 Post category:BioPharma The two companies struck the deal in 2015. Source: BioSpace You Might Also Like Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017 FDA Grants Priority Review for Prostrate Cancer Treatment March 19, 2018 Boston Scientific To Participate In 2017 Healthcare Conference August 20, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
